News about Global Pharma

Acumen Announces New Findings from Phase 1 INTERCEPT-AD Study at AAIC 2024

Acumen Pharmaceuticals, Inc. has published new findings from its Phase 1 INTERCEPT-AD study of sabirnetug (ACU193).

Global Pharma | 29/07/2024 | By Aishwarya |  618

Emcure Pharma Signs PPA with Sunsure Energy to Boost its Sustainability Initiatives

Emcure Pharmaceuticals Ltd. has signed a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, one of India's leading renewable power producers.

Global Pharma | 26/07/2024 | By Aishwarya |  1166

Mankind Pharma to Acquire Bharat Serums and Vaccines

Mankind Pharma has signed a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines Ltd. (BSV) from Advent International, for an enterprise value of approx. INR 13,630 Crores, subject to closing-related adjustments.

Global Pharma | 26/07/2024 | By Aishwarya |  910

Merck Signs MoU with Gene Therapy Research Institution

Merck has signed a non-binding Memorandum of Understanding (MoU) with Gene Therapy Research Institution Co., Ltd. (GTRI), a Japanese clinical-stage biotech start-up specializing in gene therapy using adeno-associated virus (AAV) vectors.

Global Pharma | 25/07/2024 | By Aishwarya |  700

Alembic Pharma Received FDA Approval for Fluphenazine Hydrochloride Tablets

Alembic Pharmaceuticals Ltd. has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg.

Global Pharma | 25/07/2024 | By Aishwarya |  839

Ceryx Medical Gets Trial Approval for New Pacemaker from MHRA

Ceryx Medical has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clinical trial authorisation application for the pilot RSA-pace study of the Cysoni-XT system for post-cardiac surgery patients.

Global Pharma | 24/07/2024 | By Aishwarya |  636

Gland Pharma Gets Tentative Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma Ltd. has secured tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024 percent.

Global Pharma | 24/07/2024 | By Aishwarya |  803

Union Budget 2024-25: Government Exempts Duties on Essential Medical Materials

Nirmala Sitharaman has presented the Union Budget 2024-25 in the Parliament today with a special focus on medical equipment.

Global Pharma | 23/07/2024 | By Aishwarya |  1036

Grunenthal Announces Acquisition of Valinor Pharma

Grünenthal has acquired Valinor Pharma and its product Movantik (naloxegol), with a total deal value of approx. USD 250 million, inclusive of all royalty obligations. <br />

Global Pharma | 23/07/2024 | By Aishwarya |  557

Rusan Pharma API Plant in Ankleshwar Gets USFDA GMP Approval

Rusan Pharma has announced that the United States Food and Drug Administration (USFDA) has granted Good Manufacturing Practice (GMP) approval for its Active Pharmaceutical Ingredient (API) facility in Ankleshwar (Gujarat, India).

Global Pharma | 23/07/2024 | By Aishwarya |  840